Hongcheng Cheng

1.1k total citations
17 papers, 661 citations indexed

About

Hongcheng Cheng is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Hongcheng Cheng has authored 17 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Hongcheng Cheng's work include Immune Cell Function and Interaction (5 papers), Autophagy in Disease and Therapy (4 papers) and CAR-T cell therapy research (4 papers). Hongcheng Cheng is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Autophagy in Disease and Therapy (4 papers) and CAR-T cell therapy research (4 papers). Hongcheng Cheng collaborates with scholars based in China, United States and Switzerland. Hongcheng Cheng's co-authors include Quan Chen, Yushan Zhu, Chenglong Mu, Ruize Gao, Kaili Ma, Shian Wu, Ling Chen, Biao Ma, Changqian Zhou and Jinhua Liu and has published in prestigious journals such as Nature Communications, Immunity and Nature Cell Biology.

In The Last Decade

Hongcheng Cheng

16 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongcheng Cheng China 11 377 227 134 120 116 17 661
Helena J. Janse van Rensburg Canada 12 449 1.2× 512 2.3× 162 1.2× 80 0.7× 107 0.9× 22 830
Donghong Ju United States 16 679 1.8× 276 1.2× 116 0.9× 112 0.9× 63 0.5× 41 846
Michelle Spata United States 5 275 0.7× 77 0.3× 168 1.3× 191 1.6× 161 1.4× 5 682
Nikolaos Doumpas Switzerland 7 457 1.2× 156 0.7× 62 0.5× 50 0.4× 64 0.6× 10 612
Enric Mocholí Netherlands 12 384 1.0× 185 0.8× 76 0.6× 92 0.8× 176 1.5× 21 796
Katherine Sully United Kingdom 9 267 0.7× 95 0.4× 141 1.1× 34 0.3× 104 0.9× 10 542
Aimee Flores United States 8 276 0.7× 89 0.4× 76 0.6× 141 1.2× 51 0.4× 10 502
Pushpankur Ghoshal United States 15 289 0.8× 79 0.3× 81 0.6× 88 0.7× 84 0.7× 23 520
Seiro Satohisa Japan 16 354 0.9× 89 0.4× 92 0.7× 255 2.1× 81 0.7× 27 684
Giulia Germena Germany 13 399 1.1× 216 1.0× 73 0.5× 59 0.5× 199 1.7× 21 739

Countries citing papers authored by Hongcheng Cheng

Since Specialization
Citations

This map shows the geographic impact of Hongcheng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongcheng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongcheng Cheng more than expected).

Fields of papers citing papers by Hongcheng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongcheng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongcheng Cheng. The network helps show where Hongcheng Cheng may publish in the future.

Co-authorship network of co-authors of Hongcheng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongcheng Cheng. A scholar is included among the top collaborators of Hongcheng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongcheng Cheng. Hongcheng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Ma, Kaili, Hongcheng Cheng, Lin Wang, et al.. (2025). Succinate preserves CD8+ T cell fitness to augment antitumor immunity. Immunity. 58(10). 2505–2523.e8. 4 indexed citations
3.
Qiu, Yajing, et al.. (2025). Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLoS Biology. 23(7). e3003284–e3003284. 1 indexed citations
4.
Ma, Kaili, Yingxi Xu, Hongcheng Cheng, et al.. (2025). T cell-based cancer immunotherapy: opportunities and challenges. Science Bulletin. 70(11). 1872–1890. 10 indexed citations
5.
Qiu, Yajing, Yapeng Su, Hongcheng Cheng, et al.. (2024). Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell. 43(1). 103–121.e8. 20 indexed citations
6.
Wang, Zhe, Jingzhe Shang, Yajing Qiu, et al.. (2024). Suppression of the METTL3-m6A-integrin β1 axis by extracellular acidification impairs T cell infiltration and antitumor activity. Cell Reports. 43(2). 113796–113796. 14 indexed citations
7.
Cheng, Hongcheng, Yajing Qiu, Yue Xu, et al.. (2023). Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. Nature Metabolism. 5(2). 314–330. 78 indexed citations
8.
Liu, Qiangqiang, Qian Luo, Jianyu Feng, et al.. (2022). Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression. eLife. 11. 13 indexed citations
9.
Cheng, Hongcheng, et al.. (2022). Cross-dressing of dendritic cells strengthens antitumor immunity. Trends in cancer. 8(3). 159–160. 1 indexed citations
10.
Luo, Qian, Qiangqiang Liu, Hongcheng Cheng, et al.. (2022). Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stresses. Cell Reports. 40(7). 111195–111195. 21 indexed citations
11.
Ma, Kaili, Hongcheng Cheng, & Lianjun Zhang. (2022). cBAF and MYC: decision makers for T cell memory differentiation. Signal Transduction and Targeted Therapy. 7(1). 389–389. 1 indexed citations
12.
Luo, Qian, Qiangqiang Liu, Hongcheng Cheng, et al.. (2022). Nondegradable Ubiquitinated ATG9A Organizes Golgi Integrity and Dynamics Upon Stresses. SSRN Electronic Journal. 1 indexed citations
13.
Cheng, Hongcheng, Kaili Ma, Lianjun Zhang, & Guideng Li. (2021). The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells. Cancer Letters. 506. 55–66. 30 indexed citations
14.
Ma, Kaili, Zhi Zhang, Rui Chang, et al.. (2019). Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate. Cell Death and Differentiation. 27(3). 1036–1051. 110 indexed citations
15.
Ma, Biao, Hongcheng Cheng, Chenglong Mu, et al.. (2019). The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression. Nature Communications. 10(1). 1034–1034. 65 indexed citations
16.
Ma, Biao, Hongcheng Cheng, Ruize Gao, et al.. (2016). Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nature Communications. 7(1). 11123–11123. 85 indexed citations
17.
Ma, Biao, Yan Chen, Ling Chen, et al.. (2014). Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nature Cell Biology. 17(1). 95–103. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026